GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Novel Potent Autophagy Inhibitors for Melanoma

$465,052
Jeffrey D Winkler · Wistar Institute · P01 · FY2013 · CA

Stromal Foxf2 suppresses prostate cancer progression

$465,029
Li Xin · University Of Washington · R01 · FY2023 · CA

Predictors of clinical outcome after therapeutic vaccination in follicular lympho

$465,019
Sattva S Neelapu · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA

Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors

$465,002
Wei R. Chen · University Of Oklahoma · R01 · FY2024 · CA

Metaplastic Tuft Cells in Pancreatic Cancer

$464,998
Howard C Crawford · Henry Ford Health System · R01 · FY2023 · CA

Metaplastic Tuft Cells in Pancreatic Cancer

$464,998
Howard C Crawford · Henry Ford Health System · R01 · FY2022 · CA

A Novel Plasminogen Receptor in Breast Cancer

$464,971
Barbara M Mueller · Torrey Pines Inst For Molecular Studies · R01 · FY2012 · CA

Pharmacological Blockage of XBP-1s Expression in Cancer

$464,966
Juan R Del Valle · University Of Notre Dame · R01 · FY2019 · CA

Biopsychosocial predictors of tumor-associated inflammation and progression

$464,960
Eida Maria Castro · Ponce School Of Medicine · U54 · FY2019 · MD

Mechanism of Intratumoral Transport of Particulate Drugs

$464,910
Haifa Shen · Methodist Hospital Research Institute · R01 · FY2020 · CA

Tumor Suppressor Protein, p53

$464,845
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Development of a preclinical optical frequency domain angiography instrument

$464,845
Benjamin James Vakoc · Massachusetts General Hospital · R01 · FY2012 · CA

Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity

$464,718
Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Collagen structural changes as an early biomarker for breast carcinoma

$464,700
Matthew W Conklin · University Of Wisconsin-Madison · R01 · FY2016 · CA

Rapid Motion-Robust and Easy-to-Use Dynamic Contrast-Enhanced MRI for Liver Perfusion Quantification

$464,700
Li Feng · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · EB

TLR Agonist Nano-Immune Therapy for Peritoneal Metastases

$464,569
Rita Elena Serda · University Of New Mexico Health Scis Ctr · R01 · FY2025 · CA

Synthetic lethality by targeting the core senescent mechanism in lung cancer.

$464,562
Xiao-Fan Wang · Duke University · R01 · FY2024 · CA

Dissecting the interplay between aging, genotype and the microenvironment in lung cancer

$464,561
Monte Meier Winslow · Stanford University · U01 · FY2023 · AG

Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis

$464,516
Ann Marie Pendergast · Duke University · R01 · FY2023 · CA

Multi-organ culture and pumping systems for ex vivo models of immunity in hybrid tissue-chips

$464,509
Rebecca R Pompano · University Of Virginia · R01 · FY2024 · AI

Induction of Tumor Immunity by Secreted HSP-gp96

$464,423
Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2009 · CA

Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity

$464,368
Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2022 · CA

The role of the senescent microenvironment on cancer initiating cells in the colon.

$464,341
William M Grady · Fred Hutchinson Cancer Center · U01 · FY2025 · AG

Designing Chimeric Antigen Receptor Therapies to Overcome Treg Suppression

$464,334
Crystal Mackall · Stanford University · P01 · FY2025 · CA

Principles for Designing Stimulus-Responsive Enzymes

$464,313
Sagar D Khare · Rutgers, The State Univ Of N.J. · R01 · FY2019 · GM